Tempus AI and Hims & Hers are riding healthcare IT growth, but diagnostics scale and consumer demand set different upside paths.

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024, and it ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

A significant technology, Transmission electron microscopy (TEM) has found its way into cell biology since 1940. When compared with light microscopes, TEM can achieve a very high resolution due to the ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain reaction ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best healthcare AI stocks to buy now. On December 15, JPMorgan lowered its price target on Tempus AI, Inc. (NASDAQ:TEM) from $85 to $80. The firm maintained ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Tempus AI, Inc. stands third on our list among the most promising stocks. TheFly reported on December 15 ...

In this process, the particle to be studied is exposed to electron beams under a high-resolution microscope called a transmission electron microscope and the micrographs or images captured are ...

Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM) are widely considered the gold standard for nanoparticle characterization. However, choosing which to employ is a complex ...